MoneyWorks4Me

Gland Pharma - Quaterly Results

22 May 2024 Evaluate
The sales moved up 49.58% to Rs. 11748.30 millions for the March 2024 quarter as compared to Rs. 7854.22 millions during the year-ago period.The Total revenue for the quarter ended March 2024 of  Rs. 3214.11  millions  grew by 305.79% from Rs. 792.06 millions.Operating profit for the quarter ended March 2024 rose to 4797.85 millions as compared to 2080.92 millions of corresponding quarter ended March 2023.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202403 202303 % Var 202403 202303 % Var 202403 202303 % Var
Sales 11748.30 7854.22 49.58 41674.28 36165.28 15.23 41674.28 36165.28 15.23
Other Income 469.55 389.39 20.59 1666.66 2404.64 -30.69 1666.66 2404.64 -30.69
PBIDT 4797.85 2080.92 130.56 15754.47 12590.13 25.13 15754.47 12590.13 25.13
Interest 45.34 21.81 107.89 78.43 74.14 5.79 78.43 74.14 5.79
PBDT 4752.51 1494.50 218.00 15676.04 11951.38 31.17 15676.04 11951.38 31.17
Depreciation 425.63 375.42 13.37 1621.07 1467.36 10.48 1621.07 1467.36 10.48
PBT 4326.88 1119.08 286.65 14054.97 10484.02 34.06 14054.97 10484.02 34.06
TAX 1112.77 327.02 240.28 3621.72 2725.76 32.87 3621.72 2725.76 32.87
Deferred Tax 105.98 -104.98 -200.95 246.84 -27.99 -981.89 246.84 -27.99 -981.89
PAT 3214.11 792.06 305.79 10433.25 7758.26 34.48 10433.25 7758.26 34.48
Equity 164.71 164.70 0.01 164.71 164.70 0.01 164.71 164.70 0.01
PBIDTM(%) 40.84 26.49 54.14 37.80 34.81 8.59 37.80 34.81 8.59
Peers
Company Name CMP
Sun Pharma. Inds. 1868.00
Dr. Reddys Labs. 1202.00
Cipla 1385.00
Lupin 2120.00
Zydus Lifesciences 1161.50
View more..